Mark K. H. Lee
Direttore Finanziario/CFO presso Hutchison MediPharma Ltd.
Profilo
Mark K.
H.
Lee is currently the Vice President-Corporate Finance & Development at Hutchison MediPharma Ltd.
He previously worked as a Licensing Associate at Bristol Myers Squibb Co., a Principal at Genzyme Corp.
and Nanosphere, Inc., and a Vice President at Credit Suisse First Boston Corp.
He also worked as a Principal at AstraZeneca LP.
Mr. Lee received his undergraduate degree from University College London and his MBA from MIT Sloan School of Management.
Posizioni attive di Mark K. H. Lee
| Società | Posizione | Inizio |
|---|---|---|
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Direttore Finanziario/CFO | 24/03/2010 |
Precedenti posizioni note di Mark K. H. Lee
| Società | Posizione | Fine |
|---|---|---|
| Credit Suisse First Boston Corp. | Corporate Officer/Principal | - |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| NANOSPHERE, INC. | Corporate Officer/Principal | - |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Corporate Officer/Principal | - |
Formazione di Mark K. H. Lee
| University College London | Undergraduate Degree |
| MIT Sloan School of Management | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Aziende private | 5 |
|---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
Nanosphere, Inc.
 Nanosphere, Inc. Medical SpecialtiesHealth Technology Nanosphere, Inc. engages in the development, manufacture, and market of molecular diagnostics platform. Its platform, Verigene System, enables clinicians to identify and treat bacteria and viruses responsible for some of the most complex, costly, and deadly infectious diseases. The company was founded by Chad A. Mirkin and Robert Letsinger on December 30, 1999 and is headquartered in Northbrook, IL. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| Credit Suisse First Boston Corp. | Finance |
- Borsa valori
- Insiders
- Mark K. H. Lee
